SCHEMBL4286746

SCHEMBL4286746

COc1ccc(Cc2c(O)cc(COC(C)=O)cc2Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
ALDH1A1 P00352 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 2/20 0.42
SAE1 Q9UBE0 1/20 0.42
UBA2 Q9UBT2 1/20 0.42
IGF1R P08069 1/20 0.42
ALOX15 P16050 1/20 0.42
SLC5A1 P13866 1/20 0.41
SLC5A2 P31639 1/20 0.41
HSP90AA1 P07900 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 1/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4293026 0.88 SMN1; SMN2 (0.45) ALDH1A1SMN1; SMN2LMNASLC5A1SLC5A2
SCHEMBL4291094 0.86 CYP19A1 (0.45) NFKB1NFKB2RELAALDH1A1SMN1; SMN2
SCHEMBL4293145 0.86 THRA (0.43) NPSR1NFKB1NFKB2RELAALDH1A1
SCHEMBL4291912 0.85 NFKB1 (0.42) NFKB1NFKB2RELAALDH1A1SMN1; SMN2
SCHEMBL4281489 0.85 ACACB (0.36) ALDH1A1SMN1; SMN2SLC5A1SLC5A2MEN1
SCHEMBL4294453 0.82 NFKB1 (0.40) NFKB1NFKB2RELAALDH1A1SMN1; SMN2
SCHEMBL4285302 0.80 HPGD (0.46) NPSR1NFKB1NFKB2RELAALDH1A1
SCHEMBL4289242 0.79 CYP3A4 (0.47) NFKB1NFKB2RELAALDH1A1SMN1; SMN2
SCHEMBL4287172 0.78 NPBWR1 (0.41) NFKB1NFKB2RELAALDH1A1SMN1; SMN2
SCHEMBL4292188 0.77 ALDH1A1 (0.49) NPSR1ALDH1A1SMN1; SMN2LMNAIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101472937-A Benzylphenylglucopyranoside Derivatives DAIICHI SANKYO CO LTD (JP) 2009-07-01 CN disclosed
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 NPSR1 1569/4885NFKB1 2608/4885NFKB2 1814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.